氨己烯酸改善兔实验性蛛网膜下腔出血后脑血管痉挛与继发性损伤
该研究将30只新西兰白兔分为对照组、SAH组和氨己烯酸组,每组10只,经枕大池注射自体动脉血建立SAH模型。氨己烯酸组在SAH诱导后2小时给予首剂,每日腹腔注射500 mg/kg,持续3天。结果显示氨己烯酸组基底动脉壁厚度小于SAH组、管腔面积大于SAH组,海马神经元变性评分低于SAH组,差异均有统计学意义(P < 0.001)。
要点
- 氨己烯酸可减轻兔SAH模型基底动脉壁增厚并增大管腔面积。
- 氨己烯酸降低SAH后海马CA1、CA3及齿状回神经元变性评分。
- 上述结果来自动物实验,尚不能直接推导至临床用量与疗效。
核心结论
- 氨己烯酸在兔实验性SAH模型中具有舒张血管作用,并对海马神经元继发性损伤显示神经保护效应。
研究设计与样本
- 研究共纳入30只新西兰白兔,分为对照组、SAH组和氨己烯酸组,每组10只。
- SAH模型经枕大池注射自体动脉血建立,氨己烯酸组于SAH诱导后2小时给予首剂,每日腹腔注射500 mg/kg,持续3天。
- 3天后处死动物,测量基底动脉壁厚度与管腔面积,并评估海马CA1、CA3及齿状回神经元变性。
主要发现
- 氨己烯酸组基底动脉壁厚度小于SAH组(P < 0.001)。
- 氨己烯酸组基底动脉平均管腔面积大于SAH组(P < 0.001)。
- 氨己烯酸组海马神经元变性评分低于SAH组(P < 0.001)。
临床怎么用
- 该结果为动物实验证据,提示氨己烯酸可能作为SAH后血管痉挛与继发性脑损伤的潜在干预方向,但尚未提供临床用药依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vigabatrin, an antiepileptic drug, increases the level of gamma aminobutyric acid in the brain by inhibiting its catabolism. Because gamma aminobutyric acid has been proved to have vasodilatory effects, in the present study, we investigated the effect of vigabatrin to treat experimental subarachnoid hemorrhage (SAH)-induced vasospasm. METHODS: A total of 30 New Zealand white rabbits were divided into 3 groups of 10 each: the control group, SAH group, and vigabatrin group. Experimental SAH was established by injection of autologous arterial blood into the cisterna magna. In the vigabatrin group, the rabbits were administered vigabatrin for 3 days after induction of the SAH. The first dose of vigabatrin was given 2 hours after SAH induction. A daily dose of 500 mg/kg vigabatrin was administered intraperitoneally. After 3 days, the rabbits were sacrificed, and the brains were removed, together with the cerebellum and brainstem. The basilar artery wall thickness and lumen areas were measured. The neuronal degeneration in the hippocampus (CA1, CA3, and dentate gyrus) was also evaluated. RESULTS: The arterial wall thickness of the vigabatrin group was less than that in the SAH group (P < 0.001), and the mean luminal area of the vigabatrin group was greater than that in the SAH group (P < 0.001). Additionally, the hippocampal neuronal degeneration score of the vigabatrin group was lower than that of the SAH group (P < 0.001). CONCLUSION: These findings have indicated that vigabatrin has a vasodilatory effect in an experimental SAH model in the rabbit. Moreover, it showed a neuroprotective effect in the hippocampal neurons against secondary injury induced by SAH.
引用
- Fesli R, Kuru Bektaşoğlu P, Gürer B, et al. Amelioration of Cerebral Vasospasm and Secondary Injury by Vigabatrin After Experimental Subarachnoid Hemorrhage in the Rabbit. World Neurosurg. 2020. PMID: 32492538. doi:10.1016/j.wneu.2020.05.230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。